PMDA drug package insert
オキシコドン内服液2.5mg「日本臓器」
PMDA Prescription drug · 日本臓器製薬株式会社 · package insert Jun 29, 2026
Key facts
| Brand names | オキシコドン内服液2.5mg「日本臓器」, オキシコドン内服液5mg「日本臓器」, オキシコドン内服液10mg「日本臓器」, オキシコドン内服液20mg「日本臓器」 |
|---|---|
| Nonproprietary names | オキシコドン塩酸塩水和物 |
| Companies | 製造販売元／日本臓器製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | がん疼痛治療用即放性分包内服液 |
| Therapeutic category codes | 878119 |
| YJ codes | 8119002S1027, 8119002S2023, 8119002S3020, 8119002S4026 |
| Approval numbers | 30200AMX00768000, 30200AMX00770000, 30200AMX00771000, 30200AMX00769000 |
| Package insert edition | 第4版 |
| Package insert date | Jun 29, 2026 |
| PMDA document key | 530288_8119002S1027_1 |
| PMDA company code | 530288 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: